transparent gif

 

Ej inloggad.

Göteborgs universitets publikationer

The Arachidonate 15-Lipoxygenase Enzyme Product 15-HETE Is Present in Heart Tissue from Patients with Ischemic Heart Disease and Enhances Clot Formation

Författare och institution:
Annika Lundqvist (Institutionen för biomedicin, avdelningen för klinisk kemi och transfusionsmedicin); Mikael Sandstedt (Institutionen för biomedicin, avdelningen för klinisk kemi och transfusionsmedicin); Joakim Sandstedt (Institutionen för biomedicin, avdelningen för klinisk kemi och transfusionsmedicin); Ruth Wickelgren (Institutionen för biomedicin, avdelningen för klinisk kemi och transfusionsmedicin); G. I. Hansson (-); Anders Jeppsson (Institutionen för medicin, avdelningen för molekylär och klinisk medicin); Lillemor Mattsson Hultén (Wallenberglaboratoriet)
Publicerad i:
Plos One, 11 ( 8 )
ISSN:
1932-6203
Publikationstyp:
Artikel, refereegranskad vetenskaplig
Publiceringsår:
2016
Språk:
engelska
Fulltextlänk:
Sammanfattning (abstract):
Ischemic heart disease is a major cause of death and morbidity and the search for novel therapeutic targets is still required. We have previously shown that the enzyme arachidonate 15 lipoxygenase (ALOX15), which catalyzes the conversion of arachidonic acid to 15-hydroxy eicosatetraenoic acid (15-HETE), is highly expressed in ischemic heart tissue, but its role in the pathogenesis of ischemic heart disease is unclear. Here we showed that expression of ALOX15, but not ALOX12 or ALOX15B, was increased in ischemic versus non-ischemic human heart biopsy samples. A similar ALOX expression pattern was found in hypoxic human cardiomyocytes and cardiac endothelial cells. We also showed that levels of 15-HETE were significantly higher in ischemic versus non-ischemic human heart biopsy samples and showed a tendency to increase in serum from the patients with ischemic heart disease. Moreover, hypoxia increased the production of 15-HETE levels from human cardiomyocytes and cardiac endothelial cells. The hypoxia-induced increase in 15-HETE levels from human cardiomyocytes was inhibited by the ALOX15 inhibitor baicalein. Finally, by using intrinsic rotational thromboelastometry, we showed that human whole blood clotted faster in the presence of 15-HETE. In summary, we propose that increased ALOX15 expression in heart tissue under ischemic conditions may lead to increased production of 15-HETE, potentially contributing to thrombosis.
Ämne (baseras på Högskoleverkets indelning av forskningsämnen):
MEDICIN OCH HÄLSOVETENSKAP ->
Klinisk medicin
Nyckelord:
rotation thrombelastography, cardiomyocyte clusters, expression, hypercoagulability, macrophages, samples, Science & Technology - Other Topics
Postens nummer:
241981
Posten skapad:
2016-09-19 15:54

Visa i Endnote-format

Göteborgs universitet • Tel. 031-786 0000
© Göteborgs universitet 2007